Selkirk Management’s Gilead Sciences GILD Stock Holding History

Selkirk Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-40,000	Closed	-$2.72M	–	21
2017 Q1	$2.72M	Sell	40,000 -45,000	-53%	-$3.16M	1.54%	18
2016 Q4	$6.09M	Hold	85,000	–	–	3.87%	11
2016 Q3	$6.72M	Hold	85,000	–	–	4.13%	10
2016 Q2	$7.09M	Hold	85,000	–	–	4.28%	11
2016 Q1	$7.81M	Hold	85,000	–	–	4.88%	9
2015 Q4	$8.6M	Hold	85,000	–	–	5.07%	7
2015 Q3	$8.35M	Sell	85,000 -3,256	-4%	-$362K	5.18%	8
2015 Q2	$10.3M	Hold	88,256	–	–	5.66%	6
2015 Q1	$8.66M	Sell	88,256 -40,444	-31%	-$4.11M	4.81%	9
2014 Q4	$12.1M	Hold	128,700	–	–	7.24%	4
2014 Q3	$13.7M	Hold	128,700	–	–	8.61%	3
2014 Q2	$10.7M	Hold	128,700	–	–	7.12%	5
2014 Q1	$9.12M	Buy	128,700 +28,700	+29%	+$2.25M	7.5%	5
2013 Q4	$7.51M	Hold	100,000	–	–	5.66%	7
2013 Q3	$6.29M	Hold	100,000	–	–	4.96%	7
2013 Q2	$5.13M	Buy	+100,000	New	+$5.21M	4.54%	10

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Selkirk Management's GILD Position: Q2 2017 in Review

Selkirk Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 40,000 shares — an estimated $2.72M sold.

Selkirk Management first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $13.7M in Q3 2014. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Selkirk Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Selkirk Management sold 40,000 Gilead Sciences shares in Q2 2017, an estimated $2.72M.
Selkirk Management first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
Selkirk Management's Gilead Sciences position peaked at $13.7M in Q3 2014.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Selkirk Management's 13F filing for Q2 2017, filed 14 Aug 2017.